$NVCR NovoCure Ltd Insider Trading Week 12/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd in week 12/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2019 | NVCR | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Option Exercise | A | 47.04 | 29,969 | 1,409,742 | 29,969 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Grant | A | 0.00 | 16,369 | 0 | 53,204 | 36.8 K to 53.2 K (+44.44 %) |
| Mar 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.04 | 37,461 | 1,762,165 | 37,461 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 0.00 | 20,461 | 0 | 86,725 | 66.3 K to 86.7 K (+30.88 %) |
| Mar 26 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | A | 47.04 | 44,953 | 2,114,589 | 44,953 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Grant | A | 0.00 | 24,554 | 0 | 942,860 | 918.3 K to 942.9 K (+2.67 %) |
| Mar 26 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 47.04 | 33,783 | 1,589,152 | 33,783 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Grant | A | 0.00 | 18,452 | 0 | 43,691 | 25.2 K to 43.7 K (+73.11 %) |
| Mar 26 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | A | 47.04 | 44,953 | 2,114,589 | 44,953 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Grant | A | 0.00 | 24,554 | 0 | 258,311 | 233.8 K to 258.3 K (+10.50 %) |
| Mar 26 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | A | 47.04 | 29,969 | 1,409,742 | 29,969 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Grant | A | 0.00 | 16,369 | 0 | 185,674 | 169.3 K to 185.7 K (+9.67 %) |